MERREM Drug Patent Profile

When do Merrem patents expire, and what generic alternatives are available?

Merrem is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in MERREM is meropenem. There are thirty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Merrem

A generic version of MERREM was approved as meropenem by ACS DOBFAR on October 26^th, 2011.

Summary for MERREM

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	84
Clinical Trials:	15
Patent Applications:	5,579
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for MERREM
What excipients (inactive ingredients) are in MERREM?	MERREM excipients list
DailyMed Link:	MERREM at DailyMed

See drug prices for MERREM

Recent Clinical Trials for MERREM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Wake Forest University Health Sciences	Phase 4
Johns Hopkins University	Phase 2
Hoffmann-La Roche	Phase 1

See all MERREM clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for MERREM

J01DH	Carbapenems
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for MERREM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-001	Jun 21, 1996	AP	RX	Yes	Yes
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-003	Jun 21, 1996	AP	RX	Yes	Yes

Expired US Patents for MERREM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-001	Jun 21, 1996
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-003	Jun 21, 1996

International Patents for MERREM

See the table below for patents covering MERREM around the world.

Country	Patent Number	Title	Estimated Expiration
Japan	H0466872
Canada	1283906	COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION (BETA-LACTAM COMPOUNDS AND PRODUCTION THEREOF)
Netherlands	950019
Mexico	9203063	COMPUESTOS BETA-LACTAMICOS Y PRODUCCION DE LOS MISMOS.
Hong Kong	183095	Carboxylic thio-pyrrolidinyl beta-lactam compounds and production thereof

Supplementary Protection Certificates for MERREM

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3412676	PA2020519,C3412676	Lithuania		PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120
2603514	122019000027	Germany		PRODUCT NAME: KOMBINATION VON VABORBACTAM, ODER EIN SALZ ODER EIN HYDRAT DAVON, UND MEROPENEM, ODER EIN SALZ ODER EIN HYDRAT DAVON, INSBESONDERE MEROPENEMTRIHYDRAT; REGISTRATION NO/DATE: EU/1/18/1334 20181120
3412676	PA2020519	Lithuania		PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120
0126587	96C0023	Belgium		PRODUCT NAME: MEROPENEM TRIHYDR; NAT. REGISTRATION NO/DATE: 624 IS 88 F 12 19960205; FIRST REGISTRATION: IT 028949028 19940817
2603514	SPC/GB19/021	United Kingdom		PRODUCT NAME: VABORBACTAM, AND/OR A SALT AND/OR HYDRATE THEREOF, AND MEROPENEM, AND/OR A SALT AND/OR HYDRATE THEREOF, IN PARTICULAR MEROPENEM TRIHYDRATE.; REGISTERED: UK EU/1/18/1334 (NI) 20181120; UK PLGB 16239/0061 20181120